Drug application
BRIMONIDINE TARTRATE AND TIMOLOL MALEATE (BRIMONIDINE TARTRATE, TIMOLOL MALEATE)
Drugs@FDA ANDA 091442 · APOTEX
Key facts
| Drug name | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE |
|---|---|
| Active ingredients | BRIMONIDINE TARTRATE, TIMOLOL MALEATE |
| Application type | ANDA |
| Application number | 091442 |
| Company | APOTEX |
| Dosage forms | SOLUTION/DROPS, OPHTHALMIC |
| Strength | 0.2%;EQ 0.5% BASE |
| Marketing status | Prescription |
| TE codes | AB |
| Reference listed drug | No |
| Latest submission class | Not Applicable |
| Latest submission status date | Apr 20, 2022 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 10–99 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.